Site icon pharmaceutical daily

Vaccination with certain Moderna vaccines suspended in Japan after contamination reports

Japan has been reported to have suspended the use of 1.63 million doses of Moderna’s COVID-19 vaccine, after the Takeda, the country distributor got reports of contaminants in some vials, Reuters has reported.

According to Reuters, Japan and Moderna said there were no safety or efficacy issues found and that the suspension was just a precaution.

“Moderna confirms having been notified of cases of particulate matter being seen in drug product vials of its COVID-19 vaccine,” Moderna said in a statement, Reuters reported.

“The company is investigating the reports and remains committed to working expeditiously with its partner, Takeda, and regulators to address this,” it added, referring to Japan’s Takeda Pharmaceutical, Reuters said.

Exit mobile version